Pérez GK, Fuentes VE

Language: Spanish
References: 11
Page: 1-9
PDF size: 364.81 Kb.

ABSTRACT

Introduction: Diffuse interstitial lung disease makes up a heterogeneous group of lesions with several common characteristics, among which inflammation and scarring of the organ stand out. Generally, obtaining parenchymal tissue is required for definitive diagnosis.
Objectives: To describe the outcomes of using the method of minithoracotomy or video-assisted thoracic surgery to obtain tissue samples for histopathological study.
Methods: An observational, longitudinal and prospective study was carried out with 52 consecutive patients with a diagnosis of diffuse interstitial lung disease. Tissue samples obtained by video-assisted thoracic surgery or mini-thoracotomy were taken at Hermanos Ameijeiras Clinical-Surgical Hospital, between 2001 and 2018. The age and sex of the patients, the surgical technique used, and complications and mortality were studied. The results are presented in tables, in absolute and relative numbers.
Results: The female sex predominated (59.6%). The most widely used surgical technique was minithoracotomy (75.0%) in patients between 41-50 years (15 patients). The most frequent condition was pulmonary fibrosis, accounting for 78.8%. In two patients who underwent video-assisted thoracic surgery, it was not possible to obtain any tissue for biopsy (15.4%). There were two complications in patients operated on by minithoracotomy.
Conclusions: Video-assisted thoracic surgery allows wide exploration of the lung surface, but open biopsy can be just as effective in obtaining lung tissue samples, with a minimum percentage of complications and a low mortality rate.

REFERENCES

1. Kreuter M, Herth FJF, Wacker M. Interims analysis of the exciting- ild registry(registry for exploring clinical and epidemiological characteristics of interstitial lung diseases). Eur Resp J. 2016;48(60):15-48.

2. Raghu G, Remy-Jardin M, Myers JL. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:44-68.

3. Hyldgaard C. A cohorts tudy of Danish patients with interstitial lung disease: Burden, severity, treatment and survival. Dan Med J. 2015;62(4):50- 69.

4. Theresia AM, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung disease. Clin Med (Lond). 2017;17(2):146-53.

5. Jenkins RG, Simpson JK, Saini G. Longitudinal chance in collagen degradation biomarkers in idiopathic pulmonary fibrosis: ananalysis from the prospective, multicenter profile study. Lancer Respir Med. 2015;3:462- 72.

6. Carnochan FM, Walker WS, Cameron EWJ. Efficacy of VATS lung biopsy, a historic comparison with open lung biopsy. Thorax. 2004;49:361-3.

7. Hutchinson JP, Fogarty AW, McKeever TM. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016;193:1161-7.

8. Jara-Palomares L, Martin-Juan J, Gómez-Izquierdo L, Cayuela-Domínguez A, Rodríguez-Becerra E, Rodríguez-Panadero F, et al. Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease: Prospective study of a cohort of 562 patients. Arch Bronconeumol. 2009;45:111-7.

9. Lynch DA, Sverzellati N, Travis WD. Diagnostic criterio for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6:138-53.

10. Ancochea J, Antón E, Casanova A. New treatment strategies in idiopathic pulmonary fibrosis. Arch Bronconeumol. 2014;40(Suppl 6):16-22.

11. Park JH, Kim DK, Kim DS, Koh Y, Lee SD, Kim WS, et al. Mortality and ris kfactors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur J Cardiothorac Surg. 2007;31:1115-9.